Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT04008030	TitleA Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator’s Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) ( CheckMate 8HW )	Fase Fase 3	Date Added 2019-07-05	Ubicación California, United States Colorado, United States Illinois, United States New York, United States Oregon, United States Pennsylvania, United States Texas, United States Virginia, United States Argentina Australia Austria Bélgica Brasil Canadá Chile China Czechia Dinamarca Francia Alemania Greece Ireland Italia Japón Países Bajos Noruega Puerto Rico Romania España Turkey Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Bevacizumab, cetuximab, fluorouracil, Irinotecan, Leucovorin, oxaliplatin	Etiquetas MSI-H/ MMRd
NCT ID NCT04003792	TitleTratamiento con infusión arterial hepática de oxaliplatino en combinación con quimioterapia sistémica FOLFIRI y bevacuzimab en pacientes con metástasis colorrectales hepáticas (CRLM) sólo hepáticas: Conversión a resección completa en pacientes con CRLM sólo hepáticas inicialmente inoperables.	Fase Fase 2	Date Added 2019-07-01	Ubicación Israel	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab, FOLFIRI Protocol, oxaliplatin	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03994601	TitleEstudio de inmunoterapia en investigación de BMS-986288 solo y en combinación con nivolumab en cánceres sólidos avanzados.	Fase Fase 1	Date Added 2019-06-21	Ubicación California, United States Colorado, United States Maryland, United States Missouri, United States New Jersey, United States Argentina Canadá Chile Francia Italia España	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas BMS-986288, Nivolumab, Opdivo	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03990233	TitleEnsayo de BI 765063 en monoterapia y en combinación con BI 754091 en pacientes con tumores sólidos avanzados.	Fase Fase 1	Date Added 2019-06-18	Ubicación Bélgica Francia	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas BI 754091, BI 765063	Etiquetas MSS/ MMRp
NCT ID NCT03985891	TitleEficacia del JS001 combinado con quimioterapia en pacientes con cáncer de colon localmente avanzado	Fase Fase 1/Fase 2	Date Added 2019-06-14	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Anti-PD-1 Monoclonal Antibody JS001, Chemotherapy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03984578	TitleEstudio de la ventana de oportunidad en el cáncer colorrectal	Fase Fase 2	Date Added 2019-06-13	Ubicación Singapur	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Capecitabine/ 5-FU, CapeOX, Pembrolizumab, Eloxatin, Keytruda	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03983993	TitleNiraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2019-06-12	Ubicación Georgia, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Niraparib, panitumumab, Vectibix, Zejula	Etiquetas MSS/ MMRp
NCT ID NCT03981146	TitleA Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer	Fase Fase 2	Date Added 2019-06-10	Ubicación Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Nivolumab, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT03977090	TitleGeptanolimab(GB226) combinado con fruquintinib en el tratamiento del cáncer colorrectal metastásico	Fase Fase 1	Date Added 2019-06-06	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Fruquintinib, Geptanolimab Injection, Elunate	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03970382	TitleA Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors	Fase Fase 1	Date Added 2019-05-31	Ubicación California, United States Illinois, United States New York, United States Tennessee, United States Washington, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Suspendido	Drogas IL-2, NeoTCR-P1 adoptive cell therapy, Nivolumab	Etiquetas MSS/ MMRp

Showing 181 to 190 of 299 entries